U.S. Healthcare High Growth Potential Companies

Establishment Labs Holdings

Market Cap: US$1.1b

A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

VolitionRx

Market Cap: US$49.9m

A multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally.

Ontrak

Market Cap: US$6.7m

Operates as a value-based behavioral healthcare company in the United States.

QT Imaging Holdings

Market Cap: US$22.1m

Engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, monitoring, and treatment of diseases in the United States and Internationally.

PACS Group

Market Cap: US$1.6b

Through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States.

Delcath Systems

Market Cap: US$571.5m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Owlet

Market Cap: US$82.8m

Provides digital parenting solutions in the United States, the United Kingdom, and internationally.

TELA Bio

Market Cap: US$58.5m

A commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.

Hims & Hers Health

Market Cap: US$11.9b

Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.

IceCure Medical

Market Cap: US$63.9m

A commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.

Glaukos

Market Cap: US$5.5b

An ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.

LENSAR

Market Cap: US$160.1m

A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.

NEXGEL

Market Cap: US$16.7m

Manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.

DexCom

Market Cap: US$33.5b

A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

EUDA Health Holdings

Market Cap: US$133.9m

Operates as a healthcare specialty company.

electroCore

Market Cap: US$36.5m

A bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.

Lifeward

Market Cap: US$13.6m

A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.

Nuwellis

Market Cap: US$3.9m

A medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.

Cytosorbents

Market Cap: US$51.4m

Engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally.

Co-Diagnostics

Market Cap: US$8.4m

Operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

TransMedics Group

Market Cap: US$4.3b

A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

Penumbra

Market Cap: US$10.6b

Designs, develops, manufactures, and markets medical devices in the United States and internationally.

Inspire Medical Systems

Market Cap: US$4.2b

A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

Myomo

Market Cap: US$113.0m

A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.

AtriCure

Market Cap: US$1.7b

Develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.

LifeStance Health Group

Market Cap: US$2.4b

Through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.

STAAR Surgical

Market Cap: US$936.7m

Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

Surgery Partners

Market Cap: US$2.9b

Owns and operates a network of surgical facilities and ancillary services in the United States.

DENTSPLY SIRONA

Market Cap: US$3.3b

Develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.

Globus Medical

Market Cap: US$8.1b

A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

LHC Group

Market Cap: US$5.3b

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States.

Definitive Healthcare

Market Cap: US$480.0m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Astrana Health

Market Cap: US$1.2b

A healthcare management company, provides medical care services in the United States.

GeneDx Holdings

Market Cap: US$2.0b

A genomics company, provides genetic testing services.

Simulations Plus

Market Cap: US$648.2m

Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

InnovAge Holding

Market Cap: US$545.7m

Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.